Advertisement
Screener

NIAGEN BIOSCIENCE, INC. (NAGE) Deferred Income Tax Expense (Benefit)

2.5 / 5 stars · 44/89 Roast Me

NIAGEN BIOSCIENCE, INC. Deferred Income Tax Expense (Benefit)

NIAGEN BIOSCIENCE, INC. (NAGE) reported Deferred Income Tax Expense (Benefit) of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.

Financial Statements › Cash Flow › Operating Activities

us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-03-04

  • NIAGEN BIOSCIENCE, INC. deferred income tax expense (benefit) for fiscal 2025 was $0.00.
  • NIAGEN BIOSCIENCE, INC. deferred income tax expense (benefit) for fiscal 2024 was $0.00.
  • NIAGEN BIOSCIENCE, INC. deferred income tax expense (benefit) for fiscal 2017 was $0.00.
  • NIAGEN BIOSCIENCE, INC. deferred income tax expense (benefit) for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2016.
Period endDeferred Income Tax Expense (Benefit) 12 month
2025-12-31$0.00
10-K · filed 2026-03-04
2024-12-31$0.00
10-K · filed 2026-03-04
2017-12-30$0.00
10-K · filed 2018-03-15
2016-12-31$0.00
10-K · filed 2018-03-15
2016-01-02$4.53K
10-K · filed 2018-03-15
2015-01-03$0.00
10-K · filed 2017-03-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Canopy Growth Corp (CGC)$0.395B
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87